Long Island breast cancer survivor in vaccine trial at Stony Brook
Stony Brook Cancer Center is the only Long Island site recruiting patients with early stage HER2-positive breast cancer for the clinical trial called "Flamingo." CBS News New York's Carolyn Gusoff reports.